MedPath

Cetirivin

Brand Name: Cetirivin

Generic Name: Cetirizine Dihydrochloride

Active
Registration Number

DRP-1182-05

Dosage Form

Tablet

Issuance Date

July 21, 2023

Expiry Date

December 16, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10 mg
PackagingAlu/PVC Blister Pack x 10's (Box of 100's)

Classification

C
Classification
Over-the-Counter Drug (OTC)
P
Pharmacologic
H1-Receptor Antagonist (Antihistamine)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cetirizine DihydrochlorideActive
Monograph: Cetirizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform